Literature DB >> 12743116

Crystal structure of the intrinsically flexible addiction antidote MazE.

Remy Loris1, Irina Marianovsky, Jurij Lah, Toon Laeremans, Hanna Engelberg-Kulka, Gad Glaser, Serge Muyldermans, Lode Wyns.   

Abstract

A specific camel VHH (variable domain of dromedary heavy chain antibody) fragment was used to crystallize the intrinsically flexible addiction antidote MazE. Only 45% of the polypeptide chain is found ordered in the crystal. The MazE monomer consisting of two beta-hairpins connected by a short alpha-helix has no hydrophobic core on its own and represents only one half of a typical protein domain. A complete domain structure is formed by the association of two chains, creating a hydrophobic core between two four-stranded beta-sheets. This hydrophobic core consists exclusively of short aliphatic residues. The folded part of MazE contains a novel DNA binding motif. A model for DNA binding that is consistent with the available biochemical data is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743116     DOI: 10.1074/jbc.M302336200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Antibody-enabled small-molecule drug discovery.

Authors:  Alastair D G Lawson
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

2.  Crystal structures of Phd-Doc, HigA, and YeeU establish multiple evolutionary links between microbial growth-regulating toxin-antitoxin systems.

Authors:  Mark A Arbing; Samuel K Handelman; Alexandre P Kuzin; Grégory Verdon; Chi Wang; Min Su; Francesca P Rothenbacher; Mariam Abashidze; Mohan Liu; Jennifer M Hurley; Rong Xiao; Thomas Acton; Masayori Inouye; Gaetano T Montelione; Nancy A Woychik; John F Hunt
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

3.  Structural and thermodynamic analysis of the GFP:GFP-nanobody complex.

Authors:  Marta H Kubala; Oleksiy Kovtun; Kirill Alexandrov; Brett M Collins
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

Review 4.  Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.

Authors:  Oleg Y Dmitriev; Svetlana Lutsenko; Serge Muyldermans
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

5.  Characterization of the Phd repressor-antitoxin boundary.

Authors:  James Estle McKinley; Roy David Magnuson
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

6.  Percolation of the phd repressor-operator interface.

Authors:  Xueyan Zhao; Roy David Magnuson
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

7.  Crystallization of the C-terminal domain of the addiction antidote CcdA in complex with its toxin CcdB.

Authors:  Lieven Buts; Natalie De Jonge; Remy Loris; Lode Wyns; Minh-Hoa Dao-Thi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-30

8.  The solution structure of ParD, the antidote of the ParDE toxin antitoxin module, provides the structural basis for DNA and toxin binding.

Authors:  Monika Oberer; Klaus Zangger; Karl Gruber; Walter Keller
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

9.  Driving forces of gyrase recognition by the addiction toxin CcdB.

Authors:  Mario Simic; Natalie De Jonge; Remy Loris; Gorazd Vesnaver; Jurij Lah
Journal:  J Biol Chem       Date:  2009-05-22       Impact factor: 5.157

10.  Crystallization of Doc and the Phd-Doc toxin-antitoxin complex.

Authors:  Abel Garcia-Pino; Minh-Hoa Dao-Thi; Ehud Gazit; Roy David Magnuson; Lode Wyns; Remy Loris
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.